High-Throughput Synthesis and Screening of a Cyanimide Library Identifies Selective Inhibitors of ISG15-specific Protease USP18
Raymond KooijiD, Vito PoliD, Jin Gan, Bjorn R. van DoodewaerdiD, Ayşegül SapmaziD, Günter FritziD, Klaus‐Peter KnobelochiD, Paul P. GeurinkiD
Abstract
High-throughput screening (HTS) of (large) compound collections is a critical early step in many drug discovery programs, enabling the rapid identification of lead molecules with desirable biological activity. The success of HTS depends heavily on the quality of the compound libraries used, and as such, the development of targeted libraries has emerged as a promising approach to enhance the effectiveness of HTS efforts. However, the acquisition and synthesis of such libraries remain costly and labor-intensive, often yielding compound quantities far exceeding the small amounts required for screening. To address these challenges, we present a high-throughput synthesis-to-screening method for the efficient inplate generation and immediate HTS of a deubiquitinase (DUB)-focused compound library. Central to our approach is the use of an Echo acoustic liquid handler, which enables precise nanoliter-scale transfers of DMSO-based solutions, facilitating efficient and miniaturized synthesis directly in 1,536-well plates. Using this platform, we constructed a library of 7,536 compounds featuring a DUB-privileged cyanimide warhead and screened it against a panel of twelve DUBs and ubiquitin-like proteases. This identified two structurally related molecules with selective inhibitory activity against the interferon-stimulated gene 15 (ISG15) protease USP18, which we further developed into a first-in-class USP18 inhibitor with 35 nM potency. This compound, BB07CA902, demonstrated exceptional specificity for USP18 across a panel of 41 DUBs and effectively increased ISGylation levels in cells by inhibiting USP18 activity. With our technology, we enabled the efficient preparation of large DUB-targeted cyanimide-based libraries, which will accelerate future DUB inhibitor development.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Chemical tools to define and manipulate interferon-inducible Ubl protease USP18
Griffin J. Davis, Anthony O. Omole, … Euna Yoo·Nature CommunicationsPeer-reviewed·Jan 22, 2025
- obABPP-HT*: A Precision-Engineered Activity Proteomics Pipeline for the Streamlined Discovery of Deubiquitinase Inhibitors
Hannah B. L. Jones, Simeon D. Draganov, … Adán Pinto-Fernández·bioRxiv·May 27, 2025
- Click Chemistry Enables Rapid Development of Potent sEH PROTACs Using a Direct-to-Biology Approach
Julia Schönfeld, Nick Liebisch, … Kerstin Hiesinger·Chemical CommunicationsPeer-reviewed·Jan 1, 2025
- A Proximity-Driven Functional Screening Platform for the Discovery of Noninhibitory USP7 Ligand Enabling Targeted Protein Stabilization
Kate E Young, Janitha Kumarathunga, … Weijun Gui·bioRxiv·Sep 14, 2026
- Click. Screen. Degrade. A Miniaturized D2B Workflow for rapid PROTAC Discovery
M. Mitrovic, Francesco Greco, … Stefan Knapp·Journal of Medicinal ChemistryPeer-reviewed·Jan 23, 2026
- ABPP-HT - high-throughput activity-based profiling of deubiquitylating enzyme inhibitors in a cellular context
H. Jones, R. Heilig, … A. Pinto-Fernandez·bioRxiv·Dec 10, 2020